{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:46:22Z","timestamp":1785750382212,"version":"3.56.0"},"reference-count":166,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The threat of respiratory virus infection to human health and well-being has been clearly highlighted by the coronavirus disease 2019 (COVID-19) pandemic. For people with cystic fibrosis (CF), the clinical significance of viral infections long predated the emergence of severe acute respiratory syndrome coronavirus 2. This article reviews the epidemiology, diagnosis, and treatment of respiratory virus infection in the context of CF as well as the current understanding of interactions between viruses and other microorganisms in the CF lung. The incidence of respiratory virus infection in CF varies by age with young children typically experiencing more frequent episodes than adolescents and adults. At all ages, respiratory viruses are very common in CF and are associated with pulmonary exacerbations. Respiratory viruses are identified at up to 69% of exacerbations, while viruses are also frequently detected during clinical stability. The full impact of COVID-19 in CF is yet to be established. Early studies found that rates of COVID-19 were lower in CF cohorts than in the general population. The reasons for this are unclear but may be related to the effects of shielding, infection control practices, maintenance CF therapies, or the inflammatory milieu in the CF lung. Observational studies have consistently identified that prior solid organ transplantation is a key risk factor for poor outcomes from COVID-19 in CF. Several key priorities for future research are highlighted. First, the impact of highly effective CFTR modulator therapy on the epidemiology and pathophysiology of viral infections in CF requires investigation. Second, the impact of respiratory viruses on the development and dynamics of the CF lung microbiota is poorly understood and viral infection may have important interactions with bacteria and fungi in the airway. Finally, bacteriophages represent a key focus of future investigation both for their role in transmission of antimicrobial resistance and as a promising treatment modality for multiresistant pathogens.<\/jats:p>","DOI":"10.1055\/s-0042-1758728","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T01:12:54Z","timestamp":1671498774000},"page":"196-208","source":"Crossref","is-referenced-by-count":12,"title":["Respiratory Viruses and Cystic Fibrosis"],"prefix":"10.1055","volume":"44","author":[{"given":"Kate","family":"Brackenborough","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw","family":"Ellis","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Flight","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom"},{"name":"Research and Development, GlaxoSmithKline plc, Brentford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"issue":"26","key":"ref1","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJM198412273112602","article-title":"Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis","volume":"311","author":"E E Wang","year":"1984","journal-title":"N Engl J Med"},{"issue":"08","key":"ref2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thx.2011.161117","article-title":"Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis","volume":"66","author":"K de Boer","year":"2011","journal-title":"Thorax"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"D B Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1378\/chest.121.1.64","article-title":"Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis","volume":"121","author":"M T Britto","year":"2002","journal-title":"Chest"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.1974.03230150016004","article-title":"Acute respiratory illness in an American community. The Tecumseh study","volume":"227","author":"A S Monto","year":"1974","journal-title":"JAMA"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/oxfordjournals.aje.a120595","article-title":"The Virus Watch program: a continuing surveillance of viral infections in metropolitan New York families. II. Laboratory methods and preliminary report on infections revealed by virus isolation","volume":"83","author":"I Spigland","year":"1966","journal-title":"Am J Epidemiol"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1542\/peds.103.3.619","article-title":"Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis","volume":"103","author":"P W Hiatt","year":"1999","journal-title":"Pediatrics"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1542\/peds.2007-3139","article-title":"Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study","volume":"122","author":"B E van Ewijk","year":"2008","journal-title":"Pediatrics"},{"issue":"06","key":"ref9","first-page":"662","article-title":"The effect of respiratory viral infections on patients with cystic fibrosis","volume":"143","author":"B W Ramsey","year":"1989","journal-title":"Am J Dis Child"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2016-209553","article-title":"Respiratory viruses in healthy infants and infants with cystic fibrosis: a prospective cohort study","volume":"73","author":"I Korten","year":"2018","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"105854","DOI":"10.1016\/j.rmed.2019.105854","article-title":"Respiratory viral infections in Western Australians with cystic fibrosis","volume":"161","author":"B Brestovac","year":"2020","journal-title":"Respir Med"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2013-204000","article-title":"Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis","volume":"69","author":"W G Flight","year":"2014","journal-title":"Thorax"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/adc.73.2.117","article-title":"Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis","volume":"73","author":"A R Smyth","year":"1995","journal-title":"Arch Dis Child"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcf.2007.12.002","article-title":"The role of respiratory viruses in cystic fibrosis","volume":"7","author":"D Wat","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"07","key":"ref15","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ppul.24750","article-title":"Respiratory viruses: what is their role in acute exacerbations in children with cystic fibrosis?","volume":"55","author":"M Hizal","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcf.2019.02.004","article-title":"Early respiratory viral infections in infants with cystic fibrosis","volume":"18","author":"A R Deschamp","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/thx.51.11.1115","article-title":"Effects of upper respiratory tract infections in patients with cystic fibrosis","volume":"51","author":"J Collinson","year":"1996","journal-title":"Thorax"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/ppul.20517","article-title":"Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic","volume":"41","author":"H V Olesen","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3201\/eid1606.100063","article-title":"Rhinovirus C and respiratory exacerbations in children with cystic fibrosis","volume":"16","author":"M B de Almeida","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1183\/09031936.00229114","article-title":"Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis","volume":"45","author":"A Shah","year":"2015","journal-title":"Eur Respir J"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17476348.2017.1288102","article-title":"The diagnosis and management of respiratory viral infections in cystic fibrosis","volume":"11","author":"W Flight","year":"2017","journal-title":"Expert Rev Respir Med"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10096-004-1273-7","article-title":"Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis","volume":"24","author":"G Punch","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/INF.0000000000001014","article-title":"Frequency and duration of rhinovirus infections in children with cystic fibrosis and healthy controls: a longitudinal cohort study","volume":"35","author":"J S Dijkema","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12985-019-1208-7","article-title":"Viral respiratory tract infections in young children with cystic fibrosis: a prospective full-year seasonal study","volume":"16","author":"M Eymery","year":"2019","journal-title":"Virol J"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"e0240452","DOI":"10.1371\/journal.pone.0240452","article-title":"Clinical impact of respiratory virus in pulmonary exacerbations of children with cystic fibrosis","volume":"15","author":"V MC Meyer","year":"2020","journal-title":"PLoS One"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jcv.2014.02.005","article-title":"Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients","volume":"60","author":"A Goffard","year":"2014","journal-title":"J Clin Virol"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2013.06.004","article-title":"The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation","volume":"13","author":"C Etherington","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jhin.2019.07.001","article-title":"Seasonal respiratory virus testing in management of adult cystic fibrosis patients","volume":"103","author":"S Gohil","year":"2019","journal-title":"J Hosp Infect"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cix203","article-title":"Cystic fibrosis pulmonary exacerbations attributable to respiratory syncytial virus and influenza: a population-based study","volume":"64","author":"R Somayaji","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/thx.47.2.112","article-title":"Acute severe deterioration in cystic fibrosis associated with influenza A virus infection","volume":"47","author":"S P Conway","year":"1992","journal-title":"Thorax"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/tropej\/fmy033","article-title":"Course of Illness after viral infection in Indian children with cystic fibrosis","volume":"65","author":"K M Gulla","year":"2019","journal-title":"J Trop Pediatr"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"S C Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/10408363.2011.640976","article-title":"Molecular diagnosis of respiratory virus infections","volume":"48","author":"J B Mahony","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"08","key":"ref34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"N Zhu","year":"2020","journal-title":"N Engl J Med"},{"issue":"19","key":"ref35","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"A M Zaki","year":"2012","journal-title":"N Engl J Med"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1183\/09031936.00061711","article-title":"Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples","volume":"38","author":"A M Jones","year":"2011","journal-title":"Eur Respir J"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcf.2020.09.003","article-title":"Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: a pilot study","volume":"20","author":"E Cardot-Martin","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/cid\/ciy837","article-title":"The clinical utility of point-of-care tests for influenza in ambulatory care: a systematic review and meta-analysis","volume":"69","author":"J J Lee","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref39","first-page":"CD013705","article-title":"Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection","volume":"3","author":"J Dinnes","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","article-title":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology","volume":"38","author":"A H Newton","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1055\/s-0041-1736459","article-title":"The immune response to respiratory viruses: from start to memory","volume":"42","author":"T DY Reijnders","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"M Merad","year":"2022","journal-title":"Science"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jmv.20589","article-title":"Respiratory syncytial virus infection in a murine model of cystic fibrosis","volume":"78","author":"G N Colasurdo","year":"2006","journal-title":"J Med Virol"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1165\/rcmb.2007-0417OC","article-title":"Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae","volume":"42","author":"L A Pittet","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/1040841X.2017.1297763","article-title":"Viruses in cystic fibrosis patients' airways","volume":"43","author":"L Billard","year":"2017","journal-title":"Crit Rev Microbiol"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0002-9440(10)65009-2","article-title":"Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers","volume":"156","author":"L Pizurki","year":"2000","journal-title":"Am J Pathol"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1165\/ajrcmb.19.2.3053","article-title":"Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation","volume":"19","author":"H R Black","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1183\/09031936.00054511","article-title":"Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis","volume":"39","author":"E Kieninger","year":"2012","journal-title":"Eur Respir J"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"e0143129","DOI":"10.1371\/journal.pone.0143129","article-title":"Rhinovirus load is high despite preserved interferon-\u03b2 response in cystic fibrosis bronchial epithelial cells","volume":"10","author":"N Dauletbaev","year":"2015","journal-title":"PLoS One"},{"issue":"47","key":"ref50","first-page":"346","article-title":"The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential","volume":"9","author":"M Bodas","year":"2010","journal-title":"Discov Med"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"L71","DOI":"10.1152\/ajplung.2001.281.1.L71","article-title":"Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function","volume":"281","author":"A J Weber","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"05","key":"ref52","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jinf.2020.07.021","article-title":"Differential toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection","volume":"81","author":"C Scagnolari","year":"2020","journal-title":"J Infect"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2020.01327","article-title":"Rhinovirus infection drives complex host airway molecular responses in children with cystic fibrosis","volume":"11","author":"K M Ling","year":"2020","journal-title":"Front Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3389\/fimmu.2020.00596","article-title":"Rhinovirus infection is associated with airway epithelial cell necrosis and inflammation via interleukin-1 in young children with cystic fibrosis","volume":"11","author":"S T Montgomery","year":"2020","journal-title":"Front Immunol"},{"issue":"09","key":"ref55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/jir.2006.26.609","article-title":"Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection","volume":"26","author":"W Xu","year":"2006","journal-title":"J Interferon Cytokine Res"},{"issue":"04","key":"ref56","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcf.2020.08.012","article-title":"Immune response of polarized cystic fibrosis airway epithelial cells infected with Influenza A virus","volume":"20","author":"A Sofoluwe","year":"2021","journal-title":"J Cyst Fibros"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"H GM Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"19","key":"ref58","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"P G Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcf.2020.07.004","article-title":"Ivacaftor or lumacaftor\/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirus","volume":"20","author":"E De Jong","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2021.03.017","article-title":"Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020","volume":"20","author":"L Naehrlich","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcf.2022.02.014","article-title":"A year in review: real world evidence, functional monitoring and emerging therapeutics in 2021","volume":"21","author":"H L Barr","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"e0251527","DOI":"10.1371\/journal.pone.0251527","article-title":"SARS-CoV-2 infection in cystic fibrosis: a multicentre prospective study with a control group, Italy, February-July 2020","volume":"16","author":"C Colombo","year":"2021","journal-title":"PLoS One"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s15010-021-01737-z","article-title":"Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society","volume":"50","author":"C Colombo","year":"2022","journal-title":"Infection"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2020.04.012","article-title":"A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis","volume":"19","author":"R Cosgriff","year":"2020","journal-title":"J Cyst Fibros"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"106062","DOI":"10.1016\/j.rmed.2020.106062","article-title":"Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID19-Spain survey","volume":"170","author":"P Mondejar-Lopez","year":"2020","journal-title":"Respir Med"},{"issue":"06","key":"ref66","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","article-title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","volume":"19","author":"E McClenaghan","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2020.11.021","article-title":"Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study","volume":"20","author":"R Bain","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"02","key":"ref68","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.jcf.2021.10.010","article-title":"Management of cystic fibrosis during covid-19: patient reported outcomes based remote follow-up among CF patients in Denmark\u2014a feasibility study","volume":"21","author":"L Rodkj\u00e6r","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12890-021-01528-0","article-title":"Systematic review: cystic fibrosis in the SARS-CoV-2\/COVID-19 pandemic","volume":"21","author":"H R Mathew","year":"2021","journal-title":"BMC Pulm Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jcf.2021.08.028","article-title":"Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic","volume":"20","author":"C Dowd","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"S 03","key":"ref71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2021.09.006","article-title":"Telehealth use in cystic fibrosis during COVID-19: association with race, ethnicity, and socioeconomic factors","volume":"20","author":"D Albon","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"S 10","key":"ref72","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1513\/AnnalsATS.202105-532OC","article-title":"Changes in care during the COVID-19 pandemic for people with cystic fibrosis","volume":"19","author":"D B Sanders","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"04","key":"ref73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bmjoq-2021-001427","article-title":"SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist","volume":"10","author":"R Dunk","year":"2021","journal-title":"BMJ Open Qual"},{"issue":"05","key":"ref74","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.chest.2021.11.035","article-title":"Real-world outcomes in cystic fibrosis telemedicine clinical care in a time of a global pandemic","volume":"161","author":"L AL Somerville","year":"2022","journal-title":"Chest"},{"issue":"S 01","key":"ref75","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Infection prevention and control guideline for cystic fibrosis: 2013 update","volume":"35","author":"L Saiman","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"S 01","key":"ref76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arbres.2022.03.011","article-title":"Short and long-term impact of COVID-19 infection on previous respiratory diseases","volume":"58","author":"E Chiner-Vives","year":"2022","journal-title":"Arch Bronconeumol"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13052-021-00970-4","article-title":"COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients","volume":"47","author":"A G Servidio","year":"2021","journal-title":"Ital J Pediatr"},{"issue":"05","key":"ref78","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ppul.25250","article-title":"Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic","volume":"56","author":"S Patel","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jcf.2020.07.022","article-title":"The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients","volume":"19","author":"T Havermans","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.7861\/fhj.2020-0205","article-title":"The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis","volume":"8","author":"K A Westcott","year":"2021","journal-title":"Future Healthc J"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcf.2020.12.016","article-title":"Psychological distress in adults with and without cystic fibrosis during the COVID-19 lockdown","volume":"20","author":"R Ciprandi","year":"2021","journal-title":"J Cyst Fibros"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcf.2021.08.027","article-title":"Impact of COVID-19 on mental health: effects on screening, care delivery, and people with cystic fibrosis","volume":"20","author":"B A Smith","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"09","key":"ref83","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/ppul.25537","article-title":"COVID-19: impact, experiences, and support needs of children and young adults with cystic fibrosis and parents","volume":"56","author":"N Colla\u00e7o","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2021.08.013","article-title":"A comparison of clinic and home spirometry as longitudinal outcomes in cystic fibrosis","volume":"21","author":"A Paynter","year":"2022","journal-title":"J Cyst Fibros"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcf.2021.08.023","article-title":"Telehealth after the pandemic: will the inverse care law apply? (Commentary)","volume":"20","author":"R J Calthorpe","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"03","key":"ref86","first-page":"CD001753","article-title":"Vaccines for preventing influenza in people with cystic fibrosis","author":"P Dharmaraj","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"ref87","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"N I Mazur","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"06","key":"ref88","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/INF.0000000000001501","article-title":"Respiratory syncytial virus infection-associated hospitalization rates in infants and children with cystic fibrosis","volume":"36","author":"J Metz","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"02","key":"ref89","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ppul.20751","article-title":"Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis","volume":"43","author":"K Giebels","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"ref90","first-page":"CD007743","article-title":"Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis","volume":"7","author":"K A Robinson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"05","key":"ref91","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jcf.2020.04.011","article-title":"Influenza B outbreak at an adult cystic fibrosis centre\u2014clinical impact and factors influencing spread","volume":"19","author":"J B Dennis","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"06","key":"ref92","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"T M Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref93","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial","volume":"20","author":"M G Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"ref94","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"F G Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"02","key":"ref95","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/infdis\/134.2.144","article-title":"Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis","volume":"134","author":"P F Wright","year":"1976","journal-title":"J Infect Dis"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"A Agarwal","year":"2020","journal-title":"BMJ"},{"issue":"08","key":"ref97","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nrmicro2832","article-title":"Microbial interactions: from networks to models","volume":"10","author":"K Faust","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"J S Elborn","year":"2016","journal-title":"Lancet"},{"issue":"S 01","key":"ref99","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1513\/AnnalsATS.201306-159MG","article-title":"The cystic fibrosis lung microbiome","volume":"11","author":"M G Surette","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"05","key":"ref100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2012.04.006","article-title":"Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis","volume":"11","author":"S Asner","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"03","key":"ref101","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/infdis\/jis274","article-title":"The differential clinical impact of human coronavirus species in children with cystic fibrosis","volume":"206","author":"L V da Silva Filho","year":"2012","journal-title":"J Infect Dis"},{"issue":"03","key":"ref102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/1040841X.2013.847898","article-title":"Microbiome in cystic fibrosis: shaping polymicrobial interactions for advances in antibiotic therapy","volume":"41","author":"S P Lopes","year":"2015","journal-title":"Crit Rev Microbiol"},{"issue":"07","key":"ref103","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"D M Morens","year":"2008","journal-title":"J Infect Dis"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/thx.2006.075077","article-title":"Incidence and characteristics of viral community-acquired pneumonia in adults","volume":"63","author":"L C Jennings","year":"2008","journal-title":"Thorax"},{"issue":"03","key":"ref105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/431588","article-title":"Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction","volume":"41","author":"K E Templeton","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"05","key":"ref106","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1651-2227.1981.tb05757.x","article-title":"Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma\u2013possible synergism with Pseudomonas aeruginosa","volume":"70","author":"N T Petersen","year":"1981","journal-title":"Acta Paediatr Scand"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcf.2014.11.009","article-title":"Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations","volume":"14","author":"M Chin","year":"2015","journal-title":"J Cyst Fibros"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s40064-015-1207-0","article-title":"Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization","volume":"4","author":"M Keravec","year":"2015","journal-title":"Springerplus"},{"issue":"03","key":"ref109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1513\/AnnalsATS.201211-107OC","article-title":"Changes in cystic fibrosis airway microbiota at pulmonary exacerbation","volume":"10","author":"L A Carmody","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ismej.2015.198","article-title":"Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention","volume":"10","author":"L Cuthbertson","year":"2016","journal-title":"ISME J"},{"issue":"01","key":"ref111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2049-2618-1-27","article-title":"Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation","volume":"1","author":"K E Price","year":"2013","journal-title":"Microbiome"},{"issue":"10","key":"ref112","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/thoraxjnl-2011-200932","article-title":"Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience","volume":"67","author":"F A Stressmann","year":"2012","journal-title":"Thorax"},{"issue":"11","key":"ref113","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/rccm.201205-0806OC","article-title":"Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease","volume":"186","author":"P Mallia","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref114","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1164\/rccm.201302-0341OC","article-title":"Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease","volume":"188","author":"P L Molyneaux","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2049-2618-2-22","article-title":"Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge","volume":"2","author":"E K Allen","year":"2014","journal-title":"Microbiome"},{"issue":"12","key":"ref116","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/cid\/ciy821","article-title":"The effect of influenza virus on the human oropharyngeal microbiome","volume":"68","author":"E Ramos-Sevillano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12879-014-0583-3","article-title":"Profiling bacterial community in upper respiratory tracts","volume":"14","author":"H Yi","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"03","key":"ref118","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0966-842X(00)88892-7","article-title":"Viral potentiation of bacterial superinfection of the respiratory tract","volume":"3","author":"L O Bakaletz","year":"1995","journal-title":"Trends Microbiol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/INF.0b013e3181b6d7ec","article-title":"Microbial interactions in the respiratory tract","volume":"28","author":"T F Murphy","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"07","key":"ref120","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/lary.20498","article-title":"Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously","volume":"119","author":"J H Wang","year":"2009","journal-title":"Laryngoscope"},{"issue":"02","key":"ref121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/430954","article-title":"Influenza virus neuraminidase contributes to secondary bacterial pneumonia","volume":"192","author":"V T Peltola","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"ref122","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/IAI.70.12.7161-7164.2002","article-title":"Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract","volume":"70","author":"E A Shakhnovich","year":"2002","journal-title":"Infect Immun"},{"issue":"04","key":"ref123","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"J A McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"01","key":"ref124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2014.12.010","article-title":"Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding","volume":"65","author":"M Nita-Lazar","year":"2015","journal-title":"Mol Immunol"},{"issue":"11","key":"ref125","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1462-5822.2012.01838.x","article-title":"Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells","volume":"14","author":"P Quattroni","year":"2012","journal-title":"Cell Microbiol"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chom.2014.06.005","article-title":"Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source","volume":"16","author":"S J Siegel","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"06","key":"ref127","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.jaci.2016.01.036","article-title":"Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota","volume":"137","author":"J M Mansbach","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"ref128","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/infdis\/jiw456","article-title":"Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and respiratory syncytial virus in infancy","volume":"214","author":"C Rosas-Salazar","year":"2016","journal-title":"J Infect Dis"},{"issue":"09","key":"ref129","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1164\/rccm.201602-0220OC","article-title":"Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection","volume":"194","author":"W A de Steenhuijsen Piters","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2015.03.008","article-title":"The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development","volume":"17","author":"S M Teo","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"04","key":"ref131","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaci.2013.10.049","article-title":"Nasopharyngeal Proteobacteria are associated with viral etiology and acute wheezing in children with severe bronchiolitis","volume":"133","author":"E R Hyde","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ebiom.2016.05.031","article-title":"Development of upper respiratory tract microbiota in infancy is affected by mode of delivery","volume":"9","author":"A ATM Bosch","year":"2016","journal-title":"EBioMedicine"},{"issue":"03","key":"ref133","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201401-0073OC","article-title":"The impact of breastfeeding on nasopharyngeal microbial communities in infants","volume":"190","author":"G Biesbroek","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref134","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/INF.0000000000001500","article-title":"Nasal airway microbiota profile and severe bronchiolitis in infants: a case-control study","volume":"36","author":"K Hasegawa","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fimmu.2017.00156","article-title":"The influence of the microbiome on early-life severe viral lower respiratory infections and asthma-food for thought?","volume":"8","author":"J P Lynch","year":"2017","journal-title":"Front Immunol"},{"issue":"01","key":"ref136","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaci.2013.01.009","article-title":"Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season","volume":"132","author":"K M James","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"05","key":"ref137","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","article-title":"Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7","volume":"161","author":"N Sigurs","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref138","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1183\/09031936.00193310","article-title":"Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze","volume":"39","author":"M M Kusel","year":"2012","journal-title":"Eur Respir J"},{"issue":"07","key":"ref139","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","article-title":"Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children","volume":"178","author":"D J Jackson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1164\/rccm.200804-579OC","article-title":"Evidence of a causal role of winter virus infection during infancy in early childhood asthma","volume":"178","author":"P Wu","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"ref141","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa052632","article-title":"Childhood asthma after bacterial colonization of the airway in neonates","volume":"357","author":"H Bisgaard","year":"2007","journal-title":"N Engl J Med"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"c4978","DOI":"10.1136\/bmj.c4978","article-title":"Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study","volume":"341","author":"H Bisgaard","year":"2010","journal-title":"BMJ"},{"issue":"05","key":"ref143","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jaci.2017.10.049","article-title":"Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy","volume":"142","author":"C Rosas-Salazar","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"04","key":"ref144","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4161\/viru.1.4.12071","article-title":"Deciphering the role of phage in the cystic fibrosis airway","volume":"1","author":"D Willner","year":"2010","journal-title":"Virulence"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage therapy\u2013history from Twort and d'Herelle through Soviet experience to current approaches","volume":"83","author":"N Chanishvili","year":"2012","journal-title":"Adv Virus Res"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1183\/2312508X.10016018","volume-title":"Viruses and the lung microbiome","author":"W G Flight","year":"2019"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature12212","article-title":"Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome","volume":"499","author":"S R Modi","year":"2013","journal-title":"Nature"},{"issue":"11","key":"ref148","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1093\/jac\/dkr315","article-title":"Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota","volume":"66","author":"L Fancello","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3389\/fmicb.2018.00856","article-title":"Detection of bacteriophage particles containing antibiotic resistance genes in the sputum of cystic fibrosis patients","volume":"9","author":"M Brown-Jaque","year":"2018","journal-title":"Front Microbiol"},{"issue":"11","key":"ref150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ph14111157","article-title":"Phage therapy in the 21st century: is there modern, clinical evidence of phage-mediated efficacy?","volume":"14","author":"S T Abedon","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.micro.55.1.437","article-title":"Bacteriophage therapy","volume":"55","author":"W C Summers","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"03","key":"ref152","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"A Sulakvelidze","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref153","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"A Wright","year":"2009","journal-title":"Clin Otolaryngol"},{"issue":"07","key":"ref154","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"E M Waters","year":"2017","journal-title":"Thorax"},{"issue":"03","key":"ref155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/microorganisms9030660","article-title":"Variability in bacteriophage and antibiotic sensitivity in serial Pseudomonas aeruginosa isolates from cystic fibrosis airway cultures over 12 months","volume":"9","author":"I Martin","year":"2021","journal-title":"Microorganisms"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3389\/fmicb.2016.01631","article-title":"Modular approach to select bacteriophages targeting Pseudomonas aeruginosa for their application to children suffering with cystic fibrosis","volume":"7","author":"V Krylov","year":"2016","journal-title":"Front Microbiol"},{"issue":"08","key":"ref157","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.medmal.2008.06.023","article-title":"Phage therapy experience at the Eliava Institute","volume":"38","author":"M Kutateladze","year":"2008","journal-title":"Med Mal Infect"},{"issue":"09","key":"ref158","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","article-title":"Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report","volume":"169","author":"N Hoyle","year":"2018","journal-title":"Res Microbiol"},{"issue":"11","key":"ref159","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/ppul.24945","article-title":"Combining bacteriophages with cefiderocol and meropenem\/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient","volume":"55","author":"A B Gainey","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"05","key":"ref160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"R M Dedrick","year":"2019","journal-title":"Nat Med"},{"issue":"01","key":"ref161","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/v13010060","article-title":"A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient","volume":"13","author":"D Lebeaux","year":"2021","journal-title":"Viruses"},{"issue":"11","key":"ref162","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection","volume":"185","author":"J A Nick","year":"2022","journal-title":"Cell"},{"issue":"05","key":"ref163","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","article-title":"Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens","volume":"4","author":"L Kvachadze","year":"2011","journal-title":"Microb Biotechnol"},{"issue":"04","key":"ref164","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s15010-019-01319-0","article-title":"Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient","volume":"47","author":"N Law","year":"2019","journal-title":"Infection"},{"issue":"09","key":"ref165","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/ajt.15503","article-title":"Early clinical experience of bacteriophage therapy in 3 lung transplant recipients","volume":"19","author":"S Aslam","year":"2019","journal-title":"Am J Transplant"},{"issue":"08","key":"ref166","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","article-title":"Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection","volume":"27","author":"R M Dedrick","year":"2021","journal-title":"Nat Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1758728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T08:20:56Z","timestamp":1701591656000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1758728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":166,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2023,3,9]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1758728","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]}}}